|
ATAD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.68500801989558E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.47206724377247E-12 |
| Normal-vs-Stage2 |
1.346390E-02 |
| Normal-vs-Stage3 |
5.92110005470659E-09 |
| Normal-vs-Stage4 |
3.97250000006011E-07 |
| Stage1-vs-Stage2 |
9.162800E-03 |
| Stage1-vs-Stage3 |
5.083800E-01 |
| Stage1-vs-Stage4 |
4.587800E-01 |
| Stage2-vs-Stage3 |
3.950300E-02 |
| Stage2-vs-Stage4 |
1.476090E-02 |
| Stage3-vs-Stage4 |
2.531600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06703534896724E-12 |
| Normal-vs-AfricanAmerican |
4.37770000000226E-05 |
| Normal-vs-Asian |
3.59610000000288E-07 |
| Caucasian-vs-AfricanAmerican |
1.868050E-01 |
| Caucasian-vs-Asian |
7.789400E-01 |
| AfricanAmerican-vs-Asian |
1.867030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.84920001323042E-09 |
| Normal-vs-Female |
6.8397509878082E-12 |
| Male-vs-Female |
5.367600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.2632564145606E-13 |
| Normal-vs-Age(41-60Yrs) |
1.61159999789717E-08 |
| Normal-vs-Age(61-80Yrs) |
3.73400000031054E-07 |
| Normal-vs-Age(81-100Yrs) |
2.003600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.182480E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.057700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.884600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.934000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.028200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.992000E-01 |
| Classical-VS-Follicular |
3.60859997439178E-09 |
| Classical-VS-Other |
4.437200E-01 |
| Classical-VS-Normal |
1.63169477929159E-12 |
| Tall-VS-Follicular |
1.600000E-04 |
| Tall-VS-Other |
3.218400E-01 |
| Tall-VS-Normal |
4.57579996115953E-09 |
| Follicular-VS-Other |
2.359200E-01 |
| Follicular-VS-Normal |
3.705600E-02 |
| Other-VS-Normal |
9.758800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.93790000397365E-08 |
| Normal-vs-N1 |
2.79220000010127E-07 |
| N0-vs-N1 |
8.238300E-02 |
|
|
